войтизарегистрироваться
us
О насОбратная связьРекламаPrivacy Policy
Наше мобильное приложение
Наши группы в соцсетях
Источники
еще источники
Новости
еще новости
По вашему запросу ничего не найдено

Fool

Why Edison International Stock Is Surging Today

The utility updated the market on its operations after the fires in Southern California.

5 Retirement Planning Myths That Really Have to Go

It's hard enough to put yourself into a position to really enjoy your golden years, so don't get misdirected by "truisms" that aren't true.

2 Big Telemedicine Stocks You Can't Buy Yet

If telemedicine is the future, these companies could win big.

Here's How RadNet Is Disrupting the Medical Imaging Market

The tiny company's free-standing radiology offices may only be the beginning of its story.

Alaska Airlines and Southwest Airlines Continue Their Detente

Southwest Airlines is reversing course on its previous plan to serve Paine Field, an airport in Alaska Airlines' backyard.

Why Teladoc Ought to Be on Every Growth Stock Investor's Radar

The leading telemedicine provider is growing like gangbusters, yet it could only be scratching the surface of its long-term opportunity.

Is Macy’s an Undervalued Dividend Stock?

A single digit P/E ratio and a 4% yield should attract bargain hunters.

Here's What You Should Know Before Buying Telemedicine Stocks

What it is, why it's important, and how it can overcome obstacles to adoption.

Tilray's Q3 Report Clearly Shows That It's Not Worth $10 Billion

This high-flying marijuana stock's operating results raise a number of red flags.

Forget Tesla, Inc.: Albemarle Corporation Is a Better Electric-Vehicle Stock

Tesla makes headlines, but Albermarle is a key supplier to the EV market that also has huge growth ahead of it.
Why Tilray's Still Up Over 400% in 2018 to Date

Why Tilray's Still Up Over 400% in 2018 to Date

Despite a big swoon, the recent cannabis IPO still has strong believers.

Sonos Stock Gets It Right the Second Time Around

The maker of high-end wireless audio systems sees revenue shoot higher in its first full quarter as a public company.

Why Teva Pharmaceutical Is Up 20% in 2018 So Far

Find out how the struggling generic drugmaker outperformed the market this year.

3 Top Stocks That Aren't on Wall Street's Radar

It makes sense to consider buying shares of these companies before the rest of the world catches on.

Tesla Is Prepared for a Big Fourth Quarter

The electric-car maker seems willing to do whatever it takes -- even if it means acquiring trucking companies.

NVIDIA's Earnings Were Solid, but Stock Plunges 17% on Weak Outlook Due to "Crypto Hangover"

The GPU specialist's Q4 guidance fell far short of what Wall Street was anticipating, but long-term investors have nothing to worry about.

3 Things the Market Missed About Hess' (HES) Q3 Earnings

The stock market yawned after Hess turned in a top-notch performance. Here's why you shouldn't.

10 Things You Must Know About Cronos Group's Third-Quarter Results

There are just as many questions as answers after this polarizing pot stock delivers its Q3 report.